MedPath

An Interventional Study to look at efficacy of Fluoxetine in patients with Post-stroke anxiety

Phase 2
Conditions
Health Condition 1: F419- Anxiety disorder, unspecifiedHealth Condition 2: G46- Vascular syndromes of brain in cerebrovascular diseases
Registration Number
CTRI/2018/12/016568
Lead Sponsor
Dr Satish Barki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All stroke(ischemic and hemorrhagic) and transient ischemic attack patients of age more than or equal to 18 year within six months of ictus

2. Willing to participate in the study

3. Can understand Hindi or English

Exclusion Criteria

1. Unwillingnes to participate in the study

2. Patients with aphasia or severe cognitive deficits

3. Known psychiatric diseases

4. Patients with moderate to severe depression (MAM-D > 13)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath